Organon & Co. (OGN)
(Delayed Data from NYSE)
$18.42 USD
-0.29 (-1.55%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $18.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Organon (OGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$20.43 | $27.00 | $15.00 | 9.19% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Organon comes to $20.43. The forecasts range from a low of $15.00 to a high of $27.00. The average price target represents an increase of 9.19% from the last closing price of $18.71.
Analyst Price Targets (7 )
Broker Rating
Organon currently has an average brokerage recommendation (ABR) of 2.57 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.57 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, two are Strong Buy, representing 28.57% of all recommendations. A month ago, Strong Buy represented 28.57%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.57 | 2.57 | 2.57 | 2.57 | 2.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/16/2024 | Piper Sandler | David Amsellem | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.57 |
ABR (Last week) | 2.57 |
# of Recs in ABR | 7 |
Average Target Price | $20.43 |
LT Growth Rate | 5.20% |
Industry | Medical Services |
Industry Rank by ABR | 80 of 252 |
Current Quarter EPS Est: | 0.97 |